Biogen Inc
NASDAQ: BIIB
$159.99
-$4.90 (-3.0%)
Closing Price on November 15, 2024
BIIB Articles
While investors have been enjoying ever higher dividends and buybacks at a new record, you just do not see waves and waves of stock splits any longer.
Published:
The March 13 short interest data in top biotechs have been compared with the end of February figures, and across the board all the selected stocks have seen their short interest increase.
Published:
Monday's top analyst upgrades and downgrades include AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples and Tyco International.
Published:
Friday morning, Biogen Idec announced positive results related to its Alzheimer's study. Any real Alzheimer's drug certainly would make the blockbuster category.
Published:
Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.
Published:
One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases.
Published:
24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with the mid-February figures. Across the board, all the selected stocks have seen...
Published:
24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay dividends to their shareholders.
Published:
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
Published:
The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Published:
24/7 Wall St. wanted to find out which of the major Nasdaq stocks would lead the index back over 5,000 -- and perhaps ultimately to new all-time highs.
Published:
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.
Published:
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Published:
Biogen Idec shares hit a new multiyear high Friday morning following the better-than-expected fourth-quarter earnings.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
Published: